Sierra Oncology, Inc. (SRRA)
Today's Latest Price: $16.03 USD
Updated Jan 20 6:55pm
Add SRRA to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
Sierra Oncology Inc (SRRA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Sierra Oncology Inc.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 4 | $32 | $21 | $27.75 | $16.05 | 72.9% |
SRRA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.25 | 2 | 2 | 0 | 0 | 0 | NA |
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- The upside potential (average analyst target price relative to current price) of SRRA is greater than 84.32% of all US stocks.
- SRRA has a lower variance in analysts' estimates than 30.93% of stocks in the small market cap category.
- SRRA has a higher average analyst price target than 66.96% of stocks in the small market cap category.
- SRRA has a greater number of analysts covering the stock than 35.45% of Pharmaceutical Products stocks.
- Sierra Oncology Inc's percent of analysts bearish on the stock is lower than nearly 100% of all US stocks.
- Sierra Oncology Inc's percentage of analysts bullish on the stock is higher than nearly none of all US stocks.
- SRRA has a lower change in bullishness amongst analysts than nearly 100% of all US stocks.
Stocks similar to Sierra Oncology Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are SLGL, ATHA and AKUS.
Is SRRA a Buy, Hold or Sell? See the POWR Ratings now!